" /> Miransertib Mesylate - CISMeF





Preferred Label : Miransertib Mesylate;

NCIt definition : The mesylate salt form of miransertib, an orally bioavailable inhibitor of the serine/threonine protein kinase AKT (protein kinase B), with potential antineoplastic activity. Miransertib binds to and inhibits the activity of AKT in a non-ATP competitive manner, which may result in the inhibition of the PI3K/AKT signaling pathway. This may lead to the reduction in tumor cell proliferation and the induction of tumor cell apoptosis. The AKT signaling pathway is often deregulated in cancer and is associated with tumor cell proliferation, survival and migration.;

UNII : F9613932V7;

InChIKey : LNSQWHNDOWEZII-UHFFFAOYSA-N;

CAS number : 1817727-88-0;

NCI Metathesaurus CUI : CL1382654;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
28/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.